Heritage Oak Wealth Advisors LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF $IHE

Heritage Oak Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,117 shares of the company’s stock, valued at approximately $530,000.

Several other hedge funds also recently modified their holdings of the stock. Hudock Inc. lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 3.9% during the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after acquiring an additional 114 shares during the period. O Shaughnessy Asset Management LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 35.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after purchasing an additional 120 shares during the period. National Bank of Canada FI boosted its holdings in iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after acquiring an additional 175 shares in the last quarter. Root Financial Partners LLC grew its position in iShares U.S. Pharmaceuticals ETF by 36.5% in the 1st quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after purchasing an additional 186 shares during the period. Finally, Corient Private Wealth LLC lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 3.1% in the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock valued at $552,000 after buying an additional 198 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

NYSEARCA:IHE opened at $98.29 on Thursday. iShares U.S. Pharmaceuticals ETF has a one year low of $64.94 and a one year high of $100.37. The company has a market cap of $1.11 billion, a PE ratio of 17.75 and a beta of 0.49. The firm has a 50-day moving average of $91.12 and a 200-day moving average of $88.56.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.